Ergawealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Buy |
4,962
+106
| +2% | +$19.7K | 0.41% | 30 |
|
|
2025
Q1 | $1.02M | Sell |
4,856
-100
| -2% | -$21K | 0.5% | 26 |
|
|
2024
Q4 | $881K | Hold |
4,956
| – | – | 0.44% | 26 |
|
|
2024
Q3 | $979K | Sell |
4,956
-36
| -0.7% | -$7.11K | 0.49% | 25 |
|
|
2024
Q2 | $856K | Sell |
4,992
-1,954
| -28% | -$335K | 0.47% | 27 |
|
|
2024
Q1 | $1.26M | Buy |
6,946
+2,091
| +43% | +$381K | 0.69% | 19 |
|
|
2023
Q4 | $752K | Hold |
4,855
| – | – | 0.46% | 22 |
|
|
2023
Q3 | $724K | Hold |
4,855
| – | – | 0.5% | 19 |
|
|
2023
Q2 | $654K | Buy |
4,855
+1
| +0% | +$135 | 0.45% | 19 |
|
|
2023
Q1 | $774K | Hold |
4,854
| – | – | 0.63% | 20 |
|
|
2022
Q4 | $784K | Buy |
+4,854
| New | +$784K | 0.71% | 20 |
|